Clinical Trial Update: Efficacy and Safety of Combination Therapy of Thymalfasin and Entecavir in HBeAg-positive ETV-experienced Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of combining thymosin alpha-1 with entecavir in HBeAg-positive, entecavir-experienced chronic hepatitis B patie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Baraclude (entecavir)
• Thymalfasin (thymosin alpha-1)

Snippet

Sponsor: Wen-hong Zhang | Conditions: Chronic Hepatitis b | Phase 4 | Status: UNKNOWN